GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma

Bookmark and Share
Published: 13 Jun 2020
Views: 581
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Prof Katja Weisel speaks to ecancer online at the EHA virtual conference about the GMMG-CONCEPT trial.

The GMMG-CONCEPT trial investigated the depth of response of isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) for front-line treatment of high-risk multiple myeloma.

Prof Weisel explains the results so far, and how this area of research is looking to improve over the next few years.